In addition to being associated with the underlying cancer, diarrhea may also be related to cancer treatment. A potentially ongoing challenge for cancer patients, diarrhea may also be life threatening if inadequately managed. To control and minimize the effects of diarrhea, a thorough evaluation combined with nutritional and pharmacologic measures is key. The White Paper briefly summarizes the impact of diarrhea, assessment of diarrhea, the role of the oncology nurse, and various management approaches that include evidence-based guideline recommendations.
Download a free copy of the White Paper developed by MedImmune, A Specialty Care Division of AstraZeneca, in partnership with ONS:Edge, to learn how to help your patients by assessing and controlling cancer- and treatment-related diarrhea.
©2014 MedImmune, Specialty Care Division of AstraZeneca. All rights reserved. 3024504 Last Updated 9/14